ImmuCell Corp. (ICCC)
6.24
-0.11
(-1.73%)
USD |
NASDAQ |
Jan 07, 16:00
6.30
+0.06
(+0.96%)
After-Hours: 20:00
ImmuCell Market Cap: 56.45M for Jan. 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Becton, Dickinson & Co. | 57.86B |
| AbbVie, Inc. | 412.54B |
| Precipio, Inc. | 40.77M |
| NovaBay Pharmaceuticals, Inc. | 1.341B |
| Palatin Technologies, Inc. | 16.23M |
Market Cap Related Metrics
| PE Ratio | 24.10 |
| PS Ratio | 2.022 |
| Price to Book Value | 1.894 |
| Price to Free Cash Flow | 78.50 |
| Price | 6.24 |
| Earnings Yield | 4.15% |
| Operating PE Ratio | 24.11 |
| Normalized PE Ratio | 24.10 |